LOWE CHRISTOPHER P. 4
4 · Cortexyme, Inc. · Filed Aug 18, 2021
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
LOWE CHRISTOPHER P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-08-16$2.23/sh+22,000$49,060→ 52,000 total - Sale
Common Stock
2021-08-16$95.02/sh−7,335$696,972→ 35,507 total - Sale
Common Stock
2021-08-16$96.32/sh−2,330$224,426→ 33,177 total - Exercise/Conversion
Common Stock
2021-08-17$2.23/sh+30,000$66,900→ 60,000 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-17−30,000→ 133,294 totalExercise: $2.23Exp: 2028-11-27→ Common Stock (30,000 underlying) - Sale
Common Stock
2021-08-16$94.23/sh−9,158$862,958→ 42,842 total - Sale
Common Stock
2021-08-16$98.90/sh−2,077$205,415→ 30,000 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-16−22,000→ 163,294 totalExercise: $2.23Exp: 2028-11-27→ Common Stock (22,000 underlying) - Sale
Common Stock
2021-08-16$97.28/sh−1,100$107,008→ 32,077 total
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.63 to $94.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.66 to $95.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.68 to $96.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.89 to $97.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]The option vested as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.